Asian Spectator

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Bisakah program makan bergizi gratis atasi ‘stunting’ di Indonesia?

Prabowo-Gibran yang pencalonannya sebagai Presiden dan Wakil Presiden memantik kontroversi akan bekerja mulai 20 Oktober 2024.Untuk mengawal pemerintahan mereka, kami menerbitkan edisi khusus #PantauP...

Bisakah mata uang kripto ramah lingkungan?

Mabeline72/ShutterstockMata uang kripto kerap dikritik karena minimnya kontribusi terhadap lingkungan di saat kegiatan investasi tradisional beralih ke nilai lingkungan, sosial, dan tata kelola (ESG) ...

Bagaimana cara tumbuhan berkomunikasi?

Pemandangan hutanRobsonphoto/ShutterstockPagi ini, anak saya yang berusia enam tahun masuk ke kamar dan mulai membacakan cerita dari sebuah buku. Dia mengikuti kata demi kata di halaman buku dan perla...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion